We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Synthetic Nanoparticle Has HDL's Ability To Scavenge Free Cholesterol

By LabMedica International staff writers
Posted on 21 Jan 2009
The development of a synthetic nanoparticle that mimics the structure and function of HDL (high density lipoprotein) may herald the beginning of a new era of treatment for the prevention of cardiovascular disease.

Investigators at Northwestern University (Evanston, IL, USA) used a gold nanoparticle as the core upon which to build synthetic HDL. They coated the core particle with two lipid layers, and then embedded apolipoprotein A-I (apo A-I) protein into the upper lipid layer. Apo A-I is the major protein component of HDL.
The result, which was described in the January 9, 2009, online edition of the Journal of the American Chemical Society (JACS), was a particle 18 nanometers in diameter with the surface composition of natural HDL and the ability to bind free cholesterol.

"HDL is a natural nanoparticle, and we have successfully mimicked it,” said senior author Dr. Chad A. Mirkin, professor of medicine at Northwestern University. "Gold is an ideal scaffolding material -- its size and shape can be tailored, and it can be easily functionalized. Using gold nanoparticles, which are non-toxic, for synthetic HDL bodes well for the development of a new therapeutic. We have designed and built a cholesterol sponge. The synthetic HDL features the basics of what a great cholesterol drug should be.”


Related Links:
Northwestern University


New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA

Latest BioResearch News

Study Links Midlife Vitamin D to Lower Tau in Alzheimer's
21 Jan 2009  |   BioResearch

International Consensus Standardizes Tumor Microbiota Detection and Reporting
21 Jan 2009  |   BioResearch

Common Metablolic Enzyme Could Predict Response to Cancer Immunotherapy
21 Jan 2009  |   BioResearch